1. United States Congress. H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. https://www.congress.gov/bill/116th-congress/house-bill/6074. H.R.6201 - Families First Coronavirus Response Act. https://www.congress.gov/bill/116th-congress/house-bill/6201. H.R.748 - CARES Act. https://www.congress.gov/bill/116th-congress/house-bill/748. H.R.266 - Paycheck Protection Program and Health Care Enhancement Act. https://www.congress.gov/bill/116th-congress/house-bill/266. H.R.6322 - Student Veteran Coronavirus Response Act of 2020. https://www.congress.gov/bill/116th-congress/house-bill/6322. H.R.7010 - Paycheck Protection Program Flexibility Act of 2020. https://www.congress.gov/bill/116th-congress/house-bill/7010. Accessed Jun 12, 2020.
2. Wouters OJ. Lobbying expenditures and campaign contributions by the pharmaceutical and health-product industry in the United States. 1999-2018. JAMA Intern Med. 2020;180(5):1-10. doi: https://doi.org/10.1001/jamainternmed.2020.0146
3. Steinbrook R. Lobbying, campaign contributions, and health care reform. N Engl J Med. 2009;361(23):e52. doi:https://doi.org/10.1056/NEJMp0910879
4. United States Senate. Downloadable lobbying databases. https://www.senate.gov/legislative/Public_Disclosure/database_download.htm. Accessed Jul 16, 2020.
5. Standard & Poor’s Global Market Intelligence. Compustat. http://www.compustat.com. Accessed Jul 16, 2020.